Cargando…
Safety and Efficacy of Monoclonal Antibodies for Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Published and Unpublished Clinical Trials
BACKGROUND: Monoclonal antibodies (mAbs) are currently among the most investigated targets for potential disease-modifying therapies in Alzheimer’s disease (AD). OBJECTIVE: Our objectives were to identify all registered trials investigating mAbs in MCI due to AD or AD at any stage, retrieve availabl...
Autores principales: | Lacorte, Eleonora, Ancidoni, Antonio, Zaccaria, Valerio, Remoli, Giulia, Tariciotti, Leonardo, Bellomo, Guido, Sciancalepore, Francesco, Corbo, Massimo, Lombardo, Flavia L., Bacigalupo, Ilaria, Canevelli, Marco, Piscopo, Paola, Vanacore, Nicola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198746/ https://www.ncbi.nlm.nih.gov/pubmed/35275549 http://dx.doi.org/10.3233/JAD-220046 |
Ejemplares similares
-
The Italian national survey on COVID-19 in nursing homes during the first wave of the pandemic
por: Lombardo, Flavia, et al.
Publicado: (2021) -
Anticancer drugs repurposed for Alzheimer’s disease: a systematic review
por: Ancidoni, Antonio, et al.
Publicado: (2021) -
Integrated care pathways on dementia in Italy: a survey testing the compliance with a national guidance
por: Gervasi, Giuseppe, et al.
Publicado: (2019) -
The Italian national survey on Coronavirus disease 2019 epidemic spread in nursing homes
por: Lombardo, Flavia L., et al.
Publicado: (2021) -
Adverse Events in Italian Nursing Homes During the COVID-19 Epidemic: A National Survey
por: Lombardo, Flavia L., et al.
Publicado: (2020)